Senza categoria Archives - Page 6 of 13 - Elixi International

3 December 2020

Gallium 68 PSMA-11 (Ga 68 PSMA-11)is the First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer

26 November 2020

European Commission Approves Janssen’s TREMFYA (guselkumab), a First-in-Class Treatment for Active Psoriatic Arthritis (PsA)

24 November 2020

Zokinvy (lonafarnib) is the first approved Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies

9 November 2020

New indication expands use of Brilinta (ticagrelor) beyond cardiovascular disease to patients with mild-to-moderate stroke

21 October 2020

Rekambys (rilpivirine) and Vocabria injection (cabotegravir) First long-acting injectable antiretroviral therapy for HIV

15 October 2020

Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) first FDA approved treatment for Ebola virus

5 October 2020

Opdivo (nivolumab) in combination with Yervoy (ipilimumab) newly approved first-line treatment of adults with malignant pleural mesothelioma.

2 October 2020

Jyseleca (filgotinib), approved in the EU for the treatment of adults with moderate to severe rheumatoid arthritis

27 September 2020

Nucala (mepolizumab), First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years

21 September 2020

Velphoro (sucroferric oxyhydroxide) has been approved for the treatment of children with chronic kidney disease